BioCentury | Oct 27, 2020
Distillery Therapeutics

UCSF team develops trivalent binder of SARS-CoV-2 spike for COVID-19

...the ACE2-SARS-CoV-2 S interaction in preclinical testing for COVID-19 include: a camelid neutralizing single-domain antibody from Abcore Inc....
Items per page:
1 - 1 of 1
BioCentury | Oct 27, 2020
Distillery Therapeutics

UCSF team develops trivalent binder of SARS-CoV-2 spike for COVID-19

...the ACE2-SARS-CoV-2 S interaction in preclinical testing for COVID-19 include: a camelid neutralizing single-domain antibody from Abcore Inc....
Items per page:
1 - 1 of 1